Medifast, Inc. last reported quarterly results on Oct 26, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $72.0 million (-19.4% year over year) and diluted EPS of -$1.57. It usually reports 26–48 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 16, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Tuesday. Based on last year's release for the same quarter on Feb 17, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 26–48 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 26, 2026
26 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
72
-19.4%
|
-18
-674.5%
|
-1.57
-647.6%
|
|
Aug 3, 2026
34 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
76
-27.6%
|
-3
-225.0%
|
-0.28
-227.3%
|
|
May 4, 2026
34 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
76
-34.3%
|
-2
-174.9%
|
-0.19
-171.4%
|
|
Feb 17, 2026
48 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
75
-36.9%
|
-18
-2362.0%
|
-1.65
-2358.4%
|
|
Nov 3, 2025
34 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
89
-36.2%
|
-2
-300.3%
|
-0.21
-310.0%
|
|
Aug 4, 2025
35 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
106
-37.4%
|
2
+130.4%
|
0.22
+129.3%
|
|
Apr 28, 2025
28 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
116
-33.8%
|
-1
-109.3%
|
-0.07
-109.2%
|
|
Feb 18, 2025
49 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
119
-37.7%
|
1
-86.7%
|
0.07
-86.8%
|
Company profile
- Industry
- Miscellaneous Food Preparations & Kindred Products (SIC 2090)
- Listed as
- MED (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Baltimore, MD
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 910329
- Former names
- HEALTHRITE INC (until Jan 9, 2001)
Other Miscellaneous Food Preparations & Kindred Products companies
- Mccormick & Co Inc MKC
- Utz Brands, Inc. UTZ
- Coffee Holding Co Inc JVA
- Top Wealth Group Holding Ltd TWG
All 5 Miscellaneous Food Preparations & Kindred Products companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.